Task D02: Pre-Clinical Pharmacokinetic Services
- Institution
- SRI International, CA
- Principal investigator
- Jon Mirsalis
- Funding
- $2K
- Duration
- 2019–2020
Moonbase score
Still being scored
Abstract
The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.
LOADING MOONBASE SCORE
Questions for SRI International
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · SRI InternationalNot yet scored
Task B06: PROCESS DEVELOPMENT AND SYNTHESIS OF A THERAPEUTIC FOR LASSA FEVER VIRUS
Jon Mirsalis · $1K · 2019–2020
- NIH · SRI InternationalNot yet scored
Task C13: GMP Manufacturing of Oxfendazole Clinical Trial Material and Stability Study
Jon Mirsalis · $72K · 2018–2025
- NIH · SRI International48
Nociceptin, NOPR and Sleep/Wake Control
Thomas S Kilduff · $840K · 2024–2029